1. www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145 Global Benign Prostatic Hyperplasia Treatment Market Research Report and Forecast 2025

2. Email: sales@expertmarketresearch.com Web: www.expertmarketresearch.com Phone: +1-415-325-5166 About IMARC WHO WE ARE? We are a leading market research firm with expertise in market intelligence and business research We deliver high quality, well- knitted, meaningful studies We excel at understanding and synergizing with the business priorities of our partners and delivering tailored solutions WHAT DO WE DO? Market research and business insights Competitive intelligence and benchmarking Strategy consulting Consumer surveys and feedback analysis Social and rural research Market entry strategy Syndicated Reports WHAT DO WE COVER? Food And beverages Dairy and dairy products Agriculture and farming Chemicals and materials FMCG Paper and packaging Healthcare Machinery, electronics and semiconductors WHO DO WE SERVE? Collaborating with fortune 500 companies and SMEs Serving all major clients from different industry which include Chemical & Materials, Food & Beverages, Packaging, Healthcare, Automotive, Heavy Industries, Retail, etc.

3. What We Do Cost Modeling and Cost Forecasting Competitive Intelligence and Benchmarking Country Entry Strategy Consumer Survey & Feedback Reports A good cost model supports organizations during negotiations to build strong relationships with suppliers. Cost modelling and price forecasting services from IMARC ensure clients make informed decisions. At IMARC, we help customers determine a competitor’s brand image and perception in the marketplace as compared to other key players. IMARC team drafts and implement an optimum country entry strategy for expanding business in the country. Our team of consultants deeply evaluates and strategize the market opportunities for our clients and accentuate the business in congruence with Government regulations, exports and imports scenario, demand supply gap analysis and many more. Consumer profiling, survey with end consumers, collection of their feedback and deep analysis. Based on the analysis, strategic decisions to enter in a new region, launch of new product, improvising the existing services Market Research & Business Insights To develop deep customer understanding, we employ a range of quantitative and qualitative marketing research approaches along with big data techniques that are both innovative and pragmatic Competitive Intelligence and Benchmarking Cost Modeling and Cost Forecasting Country Entry Strategy Consumer Survey & Feedback Reports Market Research & Business Insights

4. REPORT OBJECTIVES & Highlight

5. According to IMARC Group’s latest report, titled “Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global benign prostatic hyperplasia treatment market grew at a CAGR of 8% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during the next five years. Benign prostatic hyperplasia (BPH) refers to non-cancerous growth of the prostate gland that causes urethra blockage. This disorder generally results in the retention of urine, formation of bladder stones, incontinence due to overfilling, increased sensitivity of the bladder, and urinary tract infections. Some commonly used treatment methods for BPH include prescription drugs, mono drug and combination therapy, Phyto-therapies, and minimally-invasive (MI) and invasive surgeries. Resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants are some of the standard instruments used in BPH treatment surgeries. Request for a free sample copy of this report: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment- market/requestsamplehttps://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment- market/requestsample The rising prevalence of urological disorders across the globe, coupled with the growing geriatric population, is currently driving the market growth. Furthermore, the increasing consumer awareness towards the availability of efficient and minimally-invasive treatment procedures for BPH is also propelling the market. Moreover, various advancements in the medical sector have led to the development of transurethral resection of the prostate (TURP) as an efficient treatment technique. TURP is an endoscopic electrosurgical procedure that removes a portion of the prostate gland to reduce the obstruction caused by abnormal growth. In addition to this, the rising healthcare expenditures and improving healthcare infrastructures will continue to drive the market growth in the coming years. Report Description

6. Market Overview: Breakup by Treatment:  Drug Class o Alpha-Blockers o 5-Alpha-reductase Inhibitors (5-ARIs) o Phosphodiesterase-5 Enzyme Inhibitors o Others  Minimally Invasive Surgeries o Transurethral Resection of the Prostate (TURP) o Transurethral Incision of the Prostate (TUIP) o Transurethral Microwave Thermotherapy (TUMT) o Robotic Surgeries o Prostatic Urethral Lifts o Others  Laser Therapy  Others Report Description

7. Breakup by Region:  North America o United States o Canada  Asia Pacific o China o Japan o India o South Korea o Australia o Indonesia o Others  Europe o Germany o France o United Kingdom o Italy o Spain o Russia o Others  Latin America o Brazil o Mexico o Others  Middle East and Africa Report Description

8. Explore full report with table of contents: https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-markethttps://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-market Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Allergan Plc (AbbVie Inc.), Asahi Kasei Corporation, Astellas Pharma Inc., Boehringer Ingelheim GmbH (C.H. Boehringer Sohn AG & Ko. KG), Boston Scientific Corporation, GlaxoSmithKline Plc, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd. Browse Related Reports: https://www.imarcgroup.com/hardware-encryption-market https://www.imarcgroup.com/cystic-fibrosis-therapeutics-market About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Report Description

9. Contact US: IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Email: sales@imarcgroup.com USA: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800 Follow us on twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-grouphttps://www.imarcgroup.com/sales@imarcgroup.comhttps://www.linkedin.com/company/imarc-group Report Description

10. Table of Contents

11. 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Benign Prostatic Hyperplasia Treatment Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Treatment Type 6.1 Drug Class 6.1.1 Market Trends 6.1.2 Major Types 6.1.2.1 Alpha-Blockers 6.1.2.2 5-Alpha-reductase Inhibitors (5-ARIs) 6.1.2.2 Phosphodiesterase-5 Enzyme Inhibitors Table of Contents

12. 6.1.2.3 Others 6.1.3 Market Forecast 6.2 Minimally Invasive Surgeries 6.2.1 Market Trends 6.2.2 Major Types 6.2.2.1 Transurethral Resection of the Prostate (TURP) 6.2.2.2 Transurethral Incision of the Prostate (TUIP) 6.2.2.3 Transurethral Microwave Thermotherapy (TUMT) 6.2.2.4 Robotic Surgeries 6.2.2.5 Prostatic Urethral Lifts 6.2.2.6 Others 6.2.3 Market Forecast 6.3 Laser Therapy 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Region 7.1 North America 7.1.1 United States 7.1.1.1 Market Trends 7.1.1.2 Market Forecast 7.1.2 Canada 7.1.2.1 Market Trends 7.1.2.2 Market Forecast 7.2 Asia Pacific 7.2.1 China 7.2.1.1 Market Trends Table of Contents

13. 7.2.1.2 Market Forecast 7.2.2 Japan 7.2.2.1 Market Trends 7.2.2.2 Market Forecast 7.2.3 India 7.2.3.1 Market Trends 7.2.3.2 Market Forecast 7.2.4 South Korea 7.2.4.1 Market Trends 7.2.4.2 Market Forecast 7.2.5 Australia 7.2.5.1 Market Trends 7.2.5.2 Market Forecast 7.2.6 Indonesia 7.2.6.1 Market Trends 7.2.6.2 Market Forecast 7.2.7 Others 7.2.7.1 Market Trends 7.2.7.2 Market Forecast 7.3 Europe 7.3.1 Germany 7.3.1.1 Market Trends 7.3.1.2 Market Forecast 7.3.2 France 7.3.2.1 Market Trends 7.3.2.2 Market Forecast 7.3.3 United Kingdom 7.3.3.1 Market Trends 7.3.3.2 Market Forecast Table of Contents

14. 7.3.4 Italy 7.3.4.1 Market Trends 7.3.4.2 Market Forecast 7.3.5 Spain 7.3.5.1 Market Trends 7.3.5.2 Market Forecast 7.3.6 Russia 7.3.6.1 Market Trends 7.3.6.2 Market Forecast 7.3.7 Others 7.3.7.1 Market Trends 7.3.7.2 Market Forecast 7.4 Latin America 7.4.1 Brazil 7.4.1.1 Market Trends 7.4.1.2 Market Forecast 7.4.2 Mexico 7.4.2.1 Market Trends 7.4.2.2 Market Forecast 7.4.3 Others 7.4.3.1 Market Trends 7.4.3.2 Market Forecast 7.5 Middle East and Africa 7.5.1 Market Trends 7.5.2 Market Breakup by Country 7.5.3 Market Forecast 8 SWOT Analysis 8.1 Overview 8.2 Strengths Table of Contents

15. 8.3 Weaknesses 8.4 Opportunities 8.5 Threats 9 Value Chain Analysis 10 Porters Five Forces Analysis 10.1 Overview 10.2 Bargaining Power of Buyers 10.3 Bargaining Power of Suppliers 10.4 Degree of Competition 10.5 Threat of New Entrants 10.6 Threat of Substitutes 11 Price Analysis 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 Abbott Laboratories 12.3.1.1 Company Overview 12.3.1.2 Product Portfolio 12.3.1.3 Financials 12.3.1.4 SWOT Analysis 12.3.2 Allergan plc (AbbVie Inc.) 12.3.2.1 Company Overview 12.3.2.2 Product Portfolio 12.3.2.3 Financials 12.3.2.4 SWOT Analysis 12.3.3 Asahi Kasei Corporation 12.3.3.1 Company Overview 12.3.3.2 Product Portfolio Table of Contents

16. 12.3.3.3 Financials 12.3.3.4 SWOT Analysis 12.3.4 Astellas Pharma Inc. 12.3.4.1 Company Overview 12.3.4.2 Product Portfolio 12.3.4.3 Financials 12.3.4.4 SWOT Analysis 12.3.5 Boehringer Ingelheim GmbH (C.H. Boehringer Sohn AG & Ko. KG) 12.3.5.1 Company Overview 12.3.5.2 Product Portfolio 12.3.5.3 SWOT Analysis 12.3.6 Boston Scientific Corporation 12.3.6.1 Company Overview 12.3.6.2 Product Portfolio 12.3.6.3 Financials 12.3.6.4 SWOT Analysis 12.3.7 GlaxoSmithKline Plc 12.3.7.1 Company Overview 12.3.7.2 Product Portfolio 12.3.7.3 Financials 12.3.7.4 SWOT Analysis 12.3.8 Pfizer Inc. 12.3.8.1 Company Overview 12.3.8.2 Product Portfolio 12.3.8.3 Financials 12.3.8.4 SWOT Analysis 12.3.9 Sanofi S.A. 12.3.9.1 Company Overview 12.3.9.2 Product Portfolio Table of Contents

17. 12.3.9.3 Financials 12.3.9.4 SWOT Analysis 12.3.10 Teva Pharmaceutical Industries Ltd. 12.3.10.1 Company Overview 12.3.10.2 Product Portfolio 12.3.10.3 Financials 12.3.10.4 SWOT Analysis Table of Contents

18. Report FAQs Team Profile

19. Growing team of 150+ employees with deep market knowledge Over 1000 Independent Consultants from different sectors Talents from some of the top universities modelling specialists with unmatched expertise in quantitative research Individuals with experience in specific industries and having sound knowledge of targeted functional areas Commercial and non-commercial relationships with some of the top research institutes Engineers and Post Graduates Account for 75% of our Team

20. Report FAQs Words From Client

21. “We have been working with IMARC Group for over two years now. I must say that the word impossible doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I have been given them challenging assignments to work upon and have been quite impressed with their approach and results.” -Global Procurement Technology Manager – Global FMCG Giant “IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to define the path forward and launch our diagnostic successfully in the market where other players were always afraid before investing.” -Vice President Marketing – European Diagnostic Company “We were really impressed with their research findings on the South India dairy market. The innovative idea suggested by them have given us altogether different aspect to look at the problem. We started with them on small project but now thinking on doing more strategic project with them.” -National Manager (Marketing) – Indian Diary Giant “IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals of our business to low cost destinations” - Member of Board of Managing Director – Global Pharmaceutical Giant “Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive business report on the India wastewater treatment market. The finding from the reports are played a major role in our business strategies and future decision making” -Senior Vice President – Major Indian Effluent Treatment Company Words From Client

22. Report FAQs

23. 01 04 Do you provide market share information for a specific country/segment? Yes, we provide market share information and insights considering the scope. This service is provided as a part of customization requirements. I have a pre-defined budget. Can I buy chapters/sections of the report? We generally do not promote the sale of separate or individual segments from within a study, as it might fail to relay the actual meaning of the study or provide a holistic picture of the market. However, in special cases, select chapters are provided based on the client requirement. 02 My research requirement is very specific; can I customized the report? Yes, we provide customization of reports based on your requirements. It will be charged based on the scope of customization. Client have free access to pre-sales analyst briefs to discuss requirement and recommendations. 03 How do you arrive at the market numbers? Our research methodology is a three cyclic process. It starts from information procurement from our inhouse database, primary research and secondary sources. The second step is data collection and analysis. The third step is data validation from industry experts, key players and other stakeholders. 05 Do you offer post sales support? Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within the scope of study.

24. Report FAQs 08 06 Who are your client? We have engaged 550+ clients across the globe. More than half of our client are re-engage us for additional reports and services 07 How will I receive the report? The report in a PDF and Excel format will be sent to you electronically at your registered email address. Moreover, PPT and Word formats are also delivered to clients, on special requests. 09 How often does IMARC update studies? Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please contact our sales team to inquire about a report update status. Will I have to pay for the post-sale customization needs? We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this service as a pre-sale facility, we request you to share the requirements with our sales team. The research team post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and the timeline.

25. SOME OF OUR KEY CUSTOMERS